BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Xenogen Corporation 

Acquired by Caliper Life Sciences in August 2006
2061 Challenger Drive
Alameda  California  94501  U.S.A.
Phone: 510-291-6100 or 877-936-6436 Fax: 510-291-6196


SEARCH JOBS

A History of Pioneering Biophotonic Imaging & Genetic Modification Services
Founded in 1998, Xenogen is the pioneer and leader in the field of biophotonic imaging. Xenogen's VivoVision Systems utilize biophotonic imaging and serve to expedite drug discovery and development, thereby minimizing up-front costs and significantly reducing the time to market for new therapies. Non-invasive in vivo biophotonic imaging illuminates biological processes taking place in a living mammal to track biological activity in real time, at the molecular level, and provides richer and higher quality in vivo data earlier in the drug discovery and development processes.

Through VivoVision Solutions, Xenogen also provides industry-leading genetic modification technologies, including the design and production of transgenic animal models using pronuclear microinjection, gene knockin or knockout mouse techniques, breeding services, and phenotypic characterization of mouse lines.

Patented Technologies
Patented, proprietary, and licensable technologies currently in place include innovative imaging technologies and a comprehensive array of genetically modified animal creation programs. Xenogen believes that its systems and solutions can make animal testing more efficient across a broad range of applications. New applications for existing technologies and future technologies for use in genomic research and safety/toxicology are also under development.

VivoVision Systems®
Xenogen VivoVision Systems provide a “window” into the living animal that does not exist in conventional animal models. Components include:

  • IVIS® Imaging System 3D, 200, 100, and 50 Series models
  • Living Image® Software for digital image processing and analysis on Windows and Macintosh computer platforms
  • Light producing cells and microorganisms, including bacteria and human tumor cells tagged to emit light
  • Light producing animal models designed to emit light when specific genes are expressed
  • Technology licenses and contract research
VivoVision Solutions®
Xenogen VivoVision Solutions has produced over 8,000 unique transgenic mice and rats from over 2,000 transgene constructs. More than 97% of all gene constructs have successfully produced transgenic mice and rats. VivoVision Solutions offer the biomedical community an integrated array of custom animal model development capabilities, including genetic modifications, comprehensive phenotyping, and compound profiling. In vivo biophotonic imaging can be made part of genetic modification projects or custom light producing animal models.


 Key Statistics


Email: imaging@xenogen.com
Ownership: Subsidiary

Web Site: Xenogen Corporation
Employees: 130
Symbol: 
 









 Company News
Taconic Farms, Inc. Acquires Xenogen Biosciences, Subsidiary of Caliper Life Sciences, Inc. (CALP) (JOBS) 12/14/2009 8:17:07 AM    More...
Xenogen Biosciences Announces Target Validation Collaboration Agreement With Schering-Plough Corporation (SGP) 8/17/2006 11:36:14 AM    More...
Caliper Life Sciences (CALP) And Xenogen Corporation (XGEN) Announce Date Of Stockholder Meetings 7/13/2006 12:06:42 PM    More...
Xenogen Corporation (XGEN) Announces First Quarter 2006 Financial Results 5/10/2006 12:28:32 PM    More...
Xenogen Corporation (XGEN) Release: New Research Method Demonstrates Promise For Pancreatic Cancer Research And Drug Development 4/3/2006 11:19:03 AM    More...
Xenogen Corporation (XGEN) Expands Product Line With Introduction Of New Optical Imaging System 3/31/2006 11:25:22 AM    More...
Xenogen Corporation (XGEN) Announces Record 2005 Revenue Up 28% 3/3/2006 12:29:31 PM    More...
Xenogen Corporation (XGEN) Announces 2005 Fourth Quarter And Full Year Financial Results Release Date And Conference Call 2/23/2006 11:57:33 AM    More...
Caliper Life Sciences (CALP) To Acquire Xenogen Corporation (XGEN) For $80 Million 2/13/2006 10:25:13 AM    More...
Xenogen Corporation (XGEN) Announces Extension Of Global Licensing Agreement With Novartis Corporation (NVS) 12/7/2005 10:28:11 AM    More...
12345

//-->